Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Prospective Study to Assess the Efficacy and Safety of FK506 Combined MMF in the Treatment of Class III，IV，V + IV or V + III Lupus Nephritis

NCT00298506 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.

NCT NCT00298506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Prospective Study to Assess the Efficacy and Safety of FK506 Combined MMF in the Treatment of Class III，IV，V + IV or V + III Lupus Nephritis
Lead sponsor
Nanjing University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2005
Completion date
June 30, 2009
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis